Highly rated in
Highly rated in
Check Dr. Eric B. Segal's experience treating your condition:
About Dr. Eric B. Segal

Eric Segal is a Neurologist and a Child Neurologist in Hackensack, New Jersey. Segal has been practicing medicine for over 17 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Seizures, Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Generalized Tonic-Clonic Seizure. He is licensed to treat patients in New York and New Jersey. Segal is currently accepting new patients.

His clinical research consists of co-authoring 21 peer reviewed articles and participating in 4 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Eric B. Segal it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Eric B. Segal accepts the following insurance:

  •  Ambetter
20 Prospect Ave, Suite 801, Hackensack, NJ 07601
Other Locations
333 Westchester Ave, Suite E104, White Plains, NY 10604
95 Madison Ave, Morristown, NJ 07960
99 Beauvoir Ave, Summit, NJ 07901
N White Plains, NY 10603
Background & Education
Graduate Institution
Albert Einstein College Of Medicine Of Yeshiva University, 2005
Child Neurology
Pediatrics in NY
Hospital Affiliations
St Josephs University Medical Center
Garnet Health Medical Center
Chilton Medical Center
Morristown Medical Center
Newton Medical Center
Holy Name Medical Center
Overlook Medical Center
Jersey City Medical Center
Hackensack University Medical Center
Hackettstown Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors